Drug Shortage Report for JAMP DORZOLAMIDE-TIMOLOL
Report ID | 183655 |
Drug Identification Number | 02457539 |
Brand name | JAMP DORZOLAMIDE-TIMOLOL |
Common or Proper name | Dorzolamide and timolol |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL DORZOLAMIDE |
Strength(s) | 5MG 20MG |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 10mL |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-02-06 |
Estimated end date | 2023-03-10 |
Actual end date | 2023-02-17 |
Shortage status | Resolved |
Updated date | 2023-02-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-02-06 | English | Compare |
v2 | 2023-02-06 | French | Compare |
v3 | 2023-02-07 | English | Compare |
v4 | 2023-02-20 | English | Compare |
v5 | 2023-02-20 | French | Compare |
Showing 1 to 5 of 5